AFRM vs IMA · P/E 590, rev $3.22B vs rev $9.2M
Affirm Holdings Inc (AFRM) versus ImageneBio, Inc. (IMA) — a side-by-side from cached financials, not a winner call.
Affirm Holdings Inc (AFRM) is a software - infrastructure company listed on US.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Latest reported AFRM revenue for 2025-06-30 was $3.22B. Net income was $52.2M. Revenue was up 38.8% from 2024-06-30 to 2025-06-30. AFRM currently screens at market cap $28.80B and trailing P/E 589.7.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
AFRM currently screens at market cap $28.80B and trailing P/E 589.7. IMA currently screens at market cap $64.7M.
Not investment advice. Open the AFRM and IMA stock pages for the full models.
Not investment advice.